Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part III: Helminths

Omics: Approaches and applications related to diagnosis, treatment, and control of parasitic diseases. Part I: Plasmodium spp.

Assessment of the prophylactic and therapeutic effects of curcumin nanoemulsion in comparison with Spiramycin in mice simulating acute infection with T. gondii (RH strain)

Cattle buxtonellosis in Kaluga region in the Russian Federation

Comparing the anti-parasitic effect of Ivermectin versus Albendazole against intestinal nematode worms

The therapeutic efficacy of curcumin nanoemulsion versus Spiramycin in Toxoplasma gondii (ME49 strain) chronically infected mice

Cryptosporidium spp. and Helicobacter pylori in a hospitalbased study of diarrheic immunocompromised Egyptian children: Insight into risk factors, and co-infection

Combined lactophenol methylene blue-blue glycerol jelly technique as a new approach for helminths staining

Investigating the potential link between seroprevalence of Toxoplasma IgG and both types of diabetes mellitus in Benha city, Egypt

Is trichomoniasis associated with adverse preganancy outcome?

Spotlights on new publications